The WACC of Psomagen Inc (950200.KQ) is 9.4%.
| Range | Selected | |
| Cost of equity | 8.40% - 10.60% | 9.50% |
| Tax rate | -% - 0.10% | 0.05% |
| Cost of debt | 4.10% - 7.00% | 5.55% |
| WACC | 8.3% - 10.5% | 9.4% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.9 | 0.94 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.40% | 10.60% |
| Tax rate | -% | 0.10% |
| Debt/Equity ratio | 0.03 | 0.03 |
| Cost of debt | 4.10% | 7.00% |
| After-tax WACC | 8.3% | 10.5% |
| Selected WACC | 9.4% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 950200.KQ:
cost_of_equity (9.50%) = risk_free_rate (4.15%) + equity_risk_premium (5.60%) * adjusted_beta (0.9) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.